Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

Beypinar, IsmailAraz, Murat2024-02-232024-02-2320230028-47931533-4406https://doi.org/10.1056/NEJMc2306786https://hdl.handle.net/20.500.12452/12919[Abstract Not Availabe]eninfo:eu-repo/semantics/closedAccess[Keyword Not Available]Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell CarcinomaLetter3895476478375308322-s2.0-85166143198Q1WOS:00108630870001810.1056/NEJMc2306786